drugset / Trial / NCT05035849

Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose

NCT05035849

RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the study is to compare the FGM glycemic profiles in patients with type 2 diabetes mellitus treated with sitagliptin and acarbose.

Timeline

Start
2020-01-30
Primary completion
2021-04-30
Completion
2021-05-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acarbose Unknown
Comparator Sitagliptin Small molecule
Comparator Metformin Small molecule